Track Categories

The track category is the heading under which your abstract will be reviewed and later published in the conference printed matters if accepted. During the submission process, you will be asked to select one track category for your abstract.

Vaccine Research and Development involves vaccine research in the field of infectious diseases in the collective integration, including cancer, AIDS and allergies.New vaccines are constantly being researched and developed. There has been a steady progression in the advancement of vaccines that has led to development of licensed vaccines.Combination vaccines have been introduced which can prevent several diseases at once. Risk profile of vaccine against chronic diseases is moderately high when compared to those against acute diseases.

  • Track 1-1Vaccine Research in Europe
  • Track 1-2Therapeutic Vaccination for Auto Immune Diseases
  • Track 1-3Vaccine Management & Quality Assurance
  • Track 1-4Vaccine Clinical Trials
  • Track 1-5 Vaccine Discovery, Development and Formulation

Production and Research of Vaccines with the emergence and growth of new diseases, the need and demand for innovative vaccines continues to grow. But vaccine development is a complex, laborious, and expensive process. It involves a demand of multiple technologies, sufficient funds for clinical trials and manufacturing facilities, sophisticated scale-up processes, knowledge in navigating demanding regulatory environments in various regions, and managing vital safety monitoring

  • Track 2-1Concepts in Infectious Disease Research
  • Track 2-2Plants Used as Bioreactor
  • Track 2-3Preparation of the Vaccine Strain
  • Track 2-4Vaccine Database and Analysis System
  • Track 2-5Technique Used In Vaccine Production
  • Track 2-6Challenges Faced in Vaccine Discovery
  • Track 2-7Vaccine Bulk Manufacture

Vaccine design and development have been used against infectious diseases, so it is basically required a revolution in the approach to vaccine design and development. Particular vaccines are involved to act against specific diseases. For example polio vaccines are recommended for vaccination against polio virus. New technologies such as genomics, proteomics, functional genomics, and synthetic chemistry can be used for the rational identification of antigens, the synthesis of complex glycans, the generation of engineered carrier proteins, and much more that are needed in designing vaccines.Vaccine design and development services help to reduce the cost of failure and increase the chance of clinical success.

  • Track 3-1Epitope-focused Vaccine Design
  • Track 3-2Designing Vaccines in the Era of Genomics
  • Track 3-3Immunological Sequences
  • Track 3-4Structural Biology and Pathogen Entry
  • Track 3-5Interactions between Host and Pathogen
  • Track 3-6Combined Predictions
  • Track 3-7Economics of Development
  • Track 3-8Antigen Selection and Optimization
  • Track 3-9Immune Response Prediction

Vaccine development is an activity that focuses on a variety of technological initiatives and applied research, which enhance and promote improved systems and practices for vaccine safety. In the past year, the unprecedented Ebola disease outbreak galvanized research and industry response and as we continue to search for solutions, we must review the lessons learned in order to overcome the current challenges. Vaccine development is a long, complex process, often lasting 10-15 years and involving a combination of public and private involvement. The current system for developing, testing, and regulating vaccines developed during the 20th century as the groups involved standardized their procedures and regulations

  • Track 4-1Clinical Development
  • Track 4-2Assay development
  • Track 4-3Vaccine Manufacturing
  • Track 4-4Vaccine Registration and Approval
  • Track 4-5Vaccine Funding

Vaccines have helped to save millions and millions of lives. Infectious disease has always impacted humanity but with the development of vaccines the occurrence of infectious disease has been decreases. Vaccines made life more comfortable and hence various researches are still going on to cure various vaccine preventable diseases. Polio infection is on its way to eradication from all the countries and we will discuss more on the steps to eradicate polio. Polio eradication is a greatest achievement in field vaccine development. Public Health's Immunization Program aims to assist all in attaining optimal health through knowledge of and access to immunizations.

  • Track 5-1Measles Eradication
  • Track 5-2Implementation of Ideal Vaccines
  • Track 5-3Proper knowledge of Vaccines and its Uses
  • Track 5-4Protection Against Vaccine Preventable Diseases
  • Track 5-5Quality Control and Assurance of Vaccines

Immunizations help save lives, prevent serious illnesses, and are recognized as one of the most effective public health interventions available today. Vaccines immunology programs are among the most cost-effective ways to prevent disease. The success of these programs depends heavily upon the high immunization coverage of the target group and vaccine inventory management, including proper storage and handling of vaccines. This document is intended to assist all health care providers with how to properly store and handle provincially funded vaccines. Prior to storing vaccine, healthcare providers are required to understand and meet with the vaccine storage and handling requirements indicated in this document.

  • Track 6-1Vaccine Administration
  • Track 6-2Timing and Spacing of Vaccine Doses
  • Track 6-3Training and Education for Proper Storage
  • Track 6-4Vaccine Inventory Management, Transport, and Preparation

Vaccine adjuvants is a part of a vaccine that helps to create a stronger immune response in the patient’s body. Some vaccines prepared from weakened or dead germs contain naturally occurring adjuvants and aid the body produce a strong protective immune response. With the advancement of new and less reactogenic vaccine antigens, additionally comes the requirement for more viable adjuvants that will encourage the acceptance of adaptive immune responses. Vaccines made with adjuvants ensure the body to produce an immune response to protect the patient from the germ he or she is being vaccinated against. Vaccine adjuvants improve the body's immune response and often allow for smaller amounts of an inactivated virus or bacteria to be used in a vaccine.  Aluminium salts, such as aluminium hydroxide, aluminium phosphate, and aluminium potassium sulphate have been used safely as adjuvant in vaccines.

  • Track 7-1Cytokines as Adjuvants
  • Track 7-2Alum as Adjuvant
  • Track 7-3Immunologic Adjuvants
  • Track 7-4Liposomal Adjuvants
  • Track 7-5Organic Adjuvants
  • Track 7-6Inorganic Adjuvants
  • Track 7-7Mechanism of Adjuvants

Vaccines and vaccination is generally considered to be the most effective method of preventing infectious diseases. All vaccinations work by presenting a foreign antigen to the immune system in order to evoke an immune response. The purpose of every vaccination is to present a particular antigen or set of antigens to the immune system in order to evoke a relevant immune response. Vaccines help make you immune to serious diseases without getting sick. Without a vaccine, you must actually get a disease in order to become immune to the germ that causes it. Vaccines work best when they are given at certain ages. Proper timing of vaccination is key point to be noted and we would discuss various vaccines available for infants, adolescents and adults along with their schedules and risks factors involved.

  • Track 8-1Intralymphatic Vaccination
  • Track 8-2CD4+ and CD8+ T Cell Responses
  • Track 8-3Monoclonal Antibodies
  • Track 8-4 Vaccines for Routine and Selective uses
  • Track 8-5Routes of Vaccine Delivery

Conjugate Vaccines target several leading causes of vaccine-preventable deaths. Conjugate vaccines also have antigens or toxoids, often from the same bacteria, linked to the sugar molecules. Conjugate vaccines only use a small part of a bacterium linked to carrier protein. Conjugate vaccines are primarily used for the prevention of bacterial infections. Polysaccharide protein conjugate vaccines comprise of polysaccharides, generally from the surface coat of bacteria, linked to protein carriers. The advantages of the conjugate vaccines are their capacity to create immunological memory and to decrease asymptomatic carriage of the microbes, resulting in marked herd immunity. Conjugate vaccines can reduce complexity and increase coverage

  • Track 9-1Epidemiology and Methodology├é┬á
  • Track 9-2Glycoconjugate Vaccines
  • Track 9-3Hib Vaccines
  • Track 9-4Vaccines Formulation and Technologies used in Conjugated Vaccines
  • Track 9-5N. meningitidis Vaccines
  • Track 9-6S. pneumoniae Vaccines

A drug may be classified by the chemical type of the active ingredient or by the way it is used to treat a particular condition. Each drug can be classified into one or more drug classes. Bacterial vaccines is a preparation of killed or attenuated bacteria used as an active immunizing agent and a large number of deaths could be reduced by increased use of present vaccines and even more deaths can be prevented by the future use of new vaccines being developed. We would be glad to welcome and bring together the Global leaders in Immunology and relevant fields to present their research at this exclusive scientific program. Vaccine Design 2018 Organizing Committee also invites Young investigators at every career stage to submit abstracts reporting their latest scientific findings in oral and poster sessions.

  • Track 10-1Cholera Vaccines
  • Track 10-2 Pertussis (Whooping Cough) Vaccines
  • Track 10-3Tetanus Vaccine
  • Track 10-4Plague Vaccine
  • Track 10-5Influenza Vaccine

Plant-determined immunizations show another option to traditonal vaccine by encouraging sheltered and viable oral delivery through utilization of eatable plant tissue. Numerous infectious diseases enter the body through mucosal surfaces, for example, the gut, and accordingly, vaccines expressed in the form of edible plant tissues offer a select preferred advantage. The plant tissues can secure the antigen as it goes through the digestive tract. Vaccines derived from transgenic plants are convenient and inexpensive source for various bacterial, viral, protozoan and autoimmune diseases with lower capital costs.

  • Track 11-1Technology Behind Plant Vaccines
  • Track 11-2Antiviral Resistance
  • Track 11-3Agrobacterium Mediated Transformation
  • Track 11-4Chloroplast Transformation
  • Track 11-5Dengue Vaccine
  • Track 11-6 Vaccine from Tobacco Plant

DNA vaccines are used efficiently to stimulate humoral response and cellular response in animal and humans. Foreign gene will be incorporated in live host cell through R-DNA technology which induces the gene expression in the host cell. DNA vaccines are composed of bacterial plasmids. Expression plasmids are use in DNA based vaccines. Recombinant vaccines consist of some pathogen sub-units.Recombinant Vaccines are synthetic peptides that represent the protein component that induces an immune response.One of the best examples of recombinant protein vaccine currently in use in humans is the vaccine against Hepatitis B Virus (HBV).

  • Track 12-1Delivery Methods
  • Track 12-2Next generation DNA Vaccines
  • Track 12-3Recombinant Vaccines

A vaccine is a biological preparation that provides active acquired immunity to a particular disease and dates it uses back from a long time. Infections are always better if prevented then trying to cure them at later stages and the best way to ensure we are protected is to ask our healthcare provider if our vaccinations are up to date. Proper timing of vaccination is another key point to be noted and we would discuss various vaccines available for infants, adolescents and adults along with their schedules and risks factors involved.

  • Track 13-1Chickenpox Vaccines
  • Track 13-2Diphtheria Vaccines
  • Track 13-3Varicella Vaccines
  • Track 13-4Human papillomavirus (HPV) vaccines
  • Track 13-5Zoster vaccines
  • Track 13-6Measles, Mumps, Rubella (MMR) Vaccines
  • Track 13-7Pneumococcal Vaccines

Vaccines protect and prevent us from various diseases. Usually human are affected by diseases like Hepatitis B, HPV and these virus related cancers. There was experience of recital of diseases like chickenpox, mumps etc,. prior to the development and discovery of these vaccines. Vaccines present good value among health interventions and prevent from various diseases that cause discomfort and disability. Many research in science and its advances may help in production of novel vaccines. Recent development in vaccine production like recombinant, conjugate vaccines have been very successful in preventing diseases.

  • Track 14-1Tuberculosis Vaccine
  • Track 14-2Bordetella Vaccine
  • Track 14-3OPV (Oral Poliovirus Vaccine)
  • Track 14-4Meningococcal /Menactra Vaccines
  • Track 14-5Smallpox Vaccine
  • Track 14-6Rotavirus Vaccine
  • Track 14-7Cancer Vaccines

These Vaccines protect individuals who do not have HIV from contracting that virus,or therapeutic effect for persons who have or later contract HIV. There is no effective HIV vaccines currently, but research projects on clinical trials are trying to build one. There is evidence that a vaccine may be possible. Preventative medications such as antiretroviral treatments have been put into use to help prevent infection, but do not work as well as a vaccine would. The need for advance purchase commitment is a challenge in production of vaccines because governments bring the price down to marginal cost after the vaccine is being developed. Recognition of viral proteins causing various diseases by priming acquired immunity through vaccines has failed in the case of HIV. Some have stated that an HIV vaccine may not be possible without significant theoretical advances.


  • Track 15-1HIV Vaccine Strategies
  • Track 15-2T cell-based Vaccines
  • Track 15-3B cell-based Vaccines
  • Track 15-4Innate & Mucosal Immunity
  • Track 15-5Viral Vaccine Vectors

Mucosal tissues (e.g. nasal, oral, ocular, rectal, vaginal) cover a large surface of the body. It is critical to develop strategies for neutralizing the infectious agent at these surfaces because infections are initiated at these sites. Mucosal vaccination involves the administration of vaccines at one or more mucosal sites leading to induction of immune responses at that site, or other mucosal sites. Immunization involves the delivery of antigens to the mucosal immune system. The antigen delivery systems may comprise a simple buffer solution with/without adjuvants or an advanced particulate formulation, such as liposomes or nanoparticles. The most commonly evaluated route for mucosal antigen delivery is oral, but other routes have also been explored.

  • Track 16-1Edible Vaccines
  • Track 16-2 Common Vaccination given by Mucosal Route
  • Track 16-3Mucosal Vaccines Delivery
  • Track 16-4 Challenges in Mucosal Vaccine Delivery

It's important to have the right vaccinations and health advice before you travel. Its good to get the right advice - based on ones medical history, duration and season of travel. Some countries require proof of vaccination for certain diseases, like yellow fever or polio. And traveling in developing countries and rural areas may bring you into contact with more diseases, which means you might need more vaccines before you visit. It’s important to get vaccinated at least 4 to 6 weeks before you travel. This will give the vaccines time to start working, so you are protected while you are traveling. It will also usually make sure there is enough time for you to get vaccines that require more than 1 dose.

  • Track 17-1Yellow Fever Vaccine
  • Track 17-2Travelers Diarrhea
  • Track 17-3Routine Immunizations for travel

Vaccination plays an important role in large-scale commercial fish farming. In general, empirically developed vaccines based on inactivated bacterial pathogens have proven to be very efficacious in fish. Fewer commercially available viral vaccines and no parasite vaccines exist. Substantial efficacy data are available for new fish vaccines and advanced technology has been implemented. Fish vaccines can be delivered the same way we immunize warm-blooded animals. Fish can be immunized by immersion in vaccine for a short period of time. They can be immunized by injection, intramuscularly or intraperitoneally, and orally by mixing vaccines with feed. Vaccines have been a major factor in decreasing the use of antibiotics in aquaculture while keeping fish healthy. However, a vaccine is only effective if it is delivered properly into the fish, in the correct place and at the correct dose. 

  • Track 18-1 Oral Vaccination
  • Track 18-2Immersion Vaccination
  • Track 18-3Injection Vaccination
  • Track 18-4Vaccination Techniques

Main aim is to improve the health and welfare of companion animals, increase production of livestock in a cost-effective manner, and prevent animal-to-human transmission from both domestic animals and wildlife. It is considered to be cost effective and sustainable method of preventing infectious veterinary diseases. Mostly these vaccines were either inactivated organisms with adjuvants or live attenuated vaccines. These were not effective until the discovery of antigen/gene delivery system. Veterinary vaccines have a significant impact on public health through reductions in the use of veterinary pharmaceuticals and hormones and their residues in the human food chain.

  • Track 19-1Efficacy of Veterinary Medicine
  • Track 19-2Animal Health Outcomes
  • Track 19-3Recent Advances in Animal Vaccination
  • Track 19-4Current Status of Veterinary Vaccines
  • Track 19-5Vaccines for Livestock Diseases

Insilico base designing offers inexpensive, specific, potential and easy means of vaccine development and a standard approach in this post-genomic era. Epitope based vaccine designing has become a promising approach with advances in genomics, proteomics. Prediction of epitopes via in silico tools in vaccine designing process can significantly minimize the time and cost required in the development process. Traditional methods of vaccine production can be augmented by insilico approaches.

  • Track 20-1Reverse Vaccinology
  • Track 20-2Immunoinformatics Study
  • Track 20-3Conformation Analysis of Vaccines
  • Track 20-4Development of Tools and Software

Vaccines have significantly reduced the burden of infectious diseases. Recognized vaccine safety issues are commonly reported while reviews of Vaccine adjuvants are few. Vaccines are developed in accordance with the highest standards of safety because vaccines must be safe for use by as many people as possible.  Individuals respond differently to vaccines, and there is no way to absolutely guess the reaction of a specific individual to a particular vaccine. Immunization is the safest and most effective public health tool available for preventing disease and death. Efficacious vaccines protect individuals if administered before exposure.

  • Track 21-1Vaccines: A boon or curse
  • Track 21-2 Adverse Drug Reaction
  • Track 21-3Vaccine Safety Programs
  • Track 21-4Development of Pandemic Vaccines
  • Track 21-5Current Issues on Healthcare
  • Track 21-6Vaccine Preventable Diseases
  • Track 21-7Clinical and Non clinical Safety
  • Track 21-8Vaccine Pharmacovigilance

Researchers have proved that vaccine are safe to be taken. But still many find ways to skip or delay the uptake of vaccines. Survey says that regular vaccination can prevent us from various diseases. It will lead to risk of life in spreading out dosage of vaccines. There are many misconception about immunization.Not only would diseases not be disappearing without vaccines, but if we were to stop vaccinating, they would come back. Misconception often receives considerable publicity. Regular vaccination with prescribed dosage is always appreciable.

  • Track 22-1Information on the Benefits and Risks of Immunization
  • Track 22-2Cost Ratio of Immunization
  • Track 22-3Vaccine Schedule and Administration
  • Track 22-4Integrity of the Immunization Program
  • Track 22-5Global Vaccination and Challenges
  • Track 22-6Global and Regional Immunization
  • Track 22-7Future Studies